Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease

XU Xiao-juan

您当前的位置：

首页 >

文章列表页 >

Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease

更新时间：2024-09-23

- Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 18, Pages: 284-286(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
XU Xiao-juan. Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 284-286.
DOI：

XU Xiao-juan. Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 284-286. DOI：

摘要

目的: 探讨中西医结合治疗稳定期慢性阻塞性肺疾病(chronic obstructive pulmonary disease

COPD)合并肺心病的临床疗效。方法: 将明确诊断为稳定期COPD合并肺心病的100例患者随机分为对照组及观察组各50例

对照组仅给予正规西医治疗;观察组则在对照组的治疗基础上结合中医理论

加用中药进行综合治疗。两组均在治疗4周后评价疗效。结果: 治疗4周后

观察组无论是对慢性肺心病的疗效(总有效率94%)还是对呼吸系统症状改善(总有效率为82%)都明显优于对照组(总有效率分别是76%和74%

P<0.01或P<0.05)。SGRQ评分发现

观察组患者的生活质量较治疗前有了明显提高(P<0.01)。结论: 中西医结合治疗COPD合并肺心病优势明显

可提高该病的临床疗效

提高患者的生活质量。

Abstract

Objective: To investigate the Integrative Medicine clinical efficacy of treatment with stationary phase chronic obstructive pulmonary disease (COPD) with pulmonary heart disease. Method: A clear diagnosis of stationary phase COPD with pulmonary heart disease

100 patients were randomly divided into control group of 50 cases and the observation group of 50 cases

the control group only received the formal Western medical treatment;the observation group in the control group treatment program combined with traditional Chinese medicine theory

with traditional Chinese medicine to carry out comprehensive treatment. Both groups were at least 4 weeks of treatment to be evaluated. Result: After 4 weeks of treatment

the observation group

whether the efficacy of chronic pulmonary heart disease (total efficiency of 94%) or respiratory symptoms improved (total effective rate of 82%) are significantly better than the control group only to Western medicine treatment (total efficiency of 76% and 74% respectively

P<0.01 or P<0.05). In addition

the SGRQ score showed that the patients by the integrative medicine has been markedly improved quality of life of the observation group than before treatment (P<0.01). Conclusion: Integrative treatment of COPD with pulmonary heart disease have obvious advantages

can effectively increase the clinical efficacy of the disease

improve the quality of life of patients.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Integrative Medicine Treatment 50 Cases of COPD with Chronic Pulmonary Heart Disease

Effect of Modified Yangxintang on Chronic Pulmonary Heart Disease with Syndrome of Deficiency of Heart and Lung Qi

Treatment of Herpes Zoster with Middle and Severe Depressive Emotion by Longdan Xiegan Decoction

Efficiency of Chinese Herbal Medicine with Bufei Yiyang Huatan in Treating Chronic Obstructive Pulmonary Disease Patients in Stationary Phase of Pulmonary Function and Influence on Quality of Life

Related Author

XU Xiao-juan

Jin-li GUO

Zeng-zhi NIU

Yu-fang CHEN

Ping FU

Ai-qing WAMG

YANG Ya-qin

LIU Qing-yun

Related Institution

Beijing City in Changping District Xiaotangshan Community Health Service Center

Henan Vocational College of Nursing

Second Affiliated Hospital of Shanxi Medical University

Anyang People's Hospital

Department of Emergency,First Affiliated Hospital of Xinxiang Medical University,Weihui

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰